SHANGHAI, China, Nov. 27 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced Edward Hu, the Company's Chief Operating Officer, will present at the 20th Annual Piper Jaffray Healthcare Conference on Wednesday, December 3, 2008, at 12:00 pm Eastern Standard Time.
The Company will broadcast its presentation. Interested parties may access the broadcast through the Investor Relations section of the Company's web site: http://www.wuxiapptec.com .
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com .
Form more information, please contact: Debra Yu, MD Vice President Strategy WuXi PharmaTech (Cayman) Inc. Tel: +1-215-218-5559 Email: email@example.com Dr. Hai Mi Executive Director of Investor Relations and Business Planning WuXi PharmaTech (Cayman) Inc. Tel: +86-21-5046-3726 Email: firstname.lastname@example.org Juliane Snowden Vice President of Investor Relations Burns McClellan Tel: +1-212-213-0006 Email: Jsnowden@burnsmc.com
|SOURCE WuXi PharmaTech (Cayman) Inc.|
Copyright©2008 PR Newswire.
All rights reserved